Groupe d'Etude en Oncologie du Quebec

Title	CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Protocole ID	CARMA-BROS
ClinicalTrials.gov ID	NCT04151342
Cancer Type(s)	Other
Phase	Other
Stage
Study Type	Other
Drug
Institution	CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE HOPITAL FLEURIMONT 3001 12e Avenue Nord, Sherbrooke, QC, J1H 5N4
City
Principal Investigator	Dr. Nicole Bouchard
Coordinator	Anick Champoux 819-346-1110 poste 12811
Status	Recruiting
Activation Date
Eligibility Criteria	Patients ≥ 18 years at cancer diagnosis Diagnosed with malignant tumour(s) with molecular testing completed that identified rare molecular alterations Accessible/available molecular testing reports/documentation to confirm type(s) of molecular alteration(s) (resulting from the conduct of polymerase chain reaction [PCR] based next generation sequencing [NGS], immunohistochemistry [IHC], fluorescence in situ hybridization [FISH]) Canadian resident received follow-up for cancer care in Canada or is currently receiving/planning follow-up for cancer care to occur in Canada at time of enrollment
Exclusion Criteria	Previous refusal of the deceased patient, when living, to enroll in this study or patient approached for this study is unable to provide informed consent

Groupe d'étude en oncologie du Québec